Your SlideShare is downloading. ×
Chta morris-terry-canterpene-presentation-copy3
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Chta morris-terry-canterpene-presentation-copy3

445
views

Published on

Re-branding hemp as Canterpene to

Re-branding hemp as Canterpene to

Published in: Health & Medicine, Business

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
445
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • Medicine can use the 12 step HACCP methodology
    to effectively deliver an integrated service
    Here I am with my partner Silas Kanning
    and Medical Director Terry Grossman
    who is a practitioner of
    leading edge integrated medicine
  • HACCP is not a quality or efficiency system
    but fully integrates with the Define/Measure/Analyze/Improve/Control cycles
    Open source access to knowledge Facilitates
    QA/QC and Lean
  • You assemble and direct
    your personal healthspan provider team
     
  • What you plan to do with your life
    will determine the aggressiveness
    with which to apply your plan
  • From Our Family to yours
    “Live long and Prosper”.
  • Transcript

    • 1. REBRANDING HEMP FOR THE NEUTRACEUTICAL MARKET CANTERPENE AS A HEALTHSPAN EXTENSION SUPPLEMENT
    • 2. Lifespan Pharma Inc. Morris Johnson, CTO, Founder Terry Grossman, M.D., Medical Director Silas Kanning, Co-founder
    • 3. REBRANDING HEMP AS CANTERPENE MAKES SENSE FOR THE NATURAL HEALTH PRODUCT/ DSHEA FOOD SUPPLEMENT MARKETS
    • 4. 35 YEARS AGO RAPESEED EXPERIENCED THE SAME PROBLEMS AFFECTING HEMP TODAY Growers needed to rebrand something that was associated with a machine oil regarded as too toxic for humans to consume Low Erucic Acid Rapeseed (LEAR)? “CANadian source of OLeic Acid” became CANOLA It was promoted as a safe, nutritious, multi- purpose human and animal food ingredient
    • 5. Hemp is undergoing a similar identity crisisHemp is undergoing a similar identity crisis iin then the minds of many todayminds of many today
    • 6. When you Google “hemp” you get a largeWhen you Google “hemp” you get a large number of “POT” hitsnumber of “POT” hits  Purveyors of recreational and medicinalPurveyors of recreational and medicinal marijuana use “hemp” indiscriminately whenmarijuana use “hemp” indiscriminately when speaking about marijuanaspeaking about marijuana
    • 7. SOME CANADIAN HEMPSOME CANADIAN HEMP PRODUCTS ASSOCIATE HEMP WITHPRODUCTS ASSOCIATE HEMP WITH MARIJUANAMARIJUANA
    • 8. ASSOCIATING HEMP WITH MARIJUANA IS CREATING CONSUMER CONFUSION • Solutions: • Litigate? • Regulate? • Educate? • Ignore?
    • 9. AFTER MUCH CONSIDERATION WEAFTER MUCH CONSIDERATION WE CONCLUDED NONE OF THE ABOVECONCLUDED NONE OF THE ABOVE SOLUTIONS ARE PRACTICAL OR COSTSOLUTIONS ARE PRACTICAL OR COST EFFECTIVEEFFECTIVE Some hemp manufacturersSome hemp manufacturers want to capitalize on the sciencewant to capitalize on the science which has popularized thewhich has popularized the term “Medical Marijuana”term “Medical Marijuana” The best solution:The best solution: REBRANDINGREBRANDING
    • 10. REBRAND CANADIAN HEMP ASREBRAND CANADIAN HEMP AS CANTERPENECANTERPENE We link Canadian Hemp with the message “Extend Health-span and Life-span naturally with cannabis chemistry
    • 11. WE HAVE PATENTEDWE HAVE PATENTED CANTERPENE AS ACANTERPENE AS A PROPRIETARY FORMULATIONPROPRIETARY FORMULATION OF MILLED HEMPSEEDOF MILLED HEMPSEED
    • 12. AGING CAN BE BRUTAL
    • 13. IT IS POSSIBLE TO GROW OLDER WITHOUT AGING AT ANY AGE 60 yrs old 80 yrs old
    • 14. ANTIAGING IS AN ENORMOUS MARKET 76 million baby boomers in the US 6 million “boomies” in Canada Boomers now 48 – 64 and have begun to experience the “aging process” firsthand This generation has redefined each stage of their lives and is currently redefining aging
    • 15. BOOMERS REGARD AGING IS A DISEASE …
    • 16. … THAT AFFECTS EVERYONE
    • 17. … AND IS 100 PERCENT FATAL
    • 18. THIS IS THE NEW VIEW OF AGING Bob Delmonteque, age 84
    • 19. THE TWO PILLARS OF HEALTH Prevention Early Detection
    • 20. CANTERPENE CAN HELP AS A PREVENTIVE ANTIAGING STRATEGY Science has linked numerous CannabisScience has linked numerous Cannabis compounds found in Canterpene withcompounds found in Canterpene with beneficial effects on the diseases resultingbeneficial effects on the diseases resulting from “normal” agingfrom “normal” aging Canterpene captures much that otherCanterpene captures much that other conventional hemp supplements haveconventional hemp supplements have ignoredignored
    • 21. Can Canterpene work as a lifespanCan Canterpene work as a lifespan enhancement tool?enhancement tool?
    • 22. THE MEDICAL BENEFITS CANTERPENE
    • 23. NUMEROUS BIOCHEMICAL BENEFITS OF CANNABINOIDS IN HEMP
    • 24. SOME DISEASES/CONDITIONS ASSOCIATED WITH AGING Oxidative stress Arthritis Central nervous system degeneration Parkinson’s Alzheimer’s Cannabidiol (CBD) the major cannabinoid in hemp has been shown to be of benefit in each of these and many other conditions
    • 25. OXIDATIVE STRESS CBD treatmentsignificantly reduced oxidative stress; decreased the levelsof tumor necrosis factor, vascular endothelial growth factor,and intercellular adhesion molecule-1; and prevented retinalcell death and vascular hyperpermeability in the diabetic retina.Consistent with these effects, CBD treatment also significantlyinhibited p38 MAP kinase in the diabetic retina. These resultsdemonstrate that CBD treatment reduces neurotoxicity, inflammation,and BRB breakdown in diabetic animals. EL Remessey AB et al. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol. 2006 Jan;168(1):235-44.
    • 26. ARTHRITIS These potentially anti-inflammatory properties of CBD, together with the lack of psychotropic effect and low toxicity prompted us to test the potential of CBD as a therapeutic agent in collagen-induced arthritis (CIA). RESULTS: “We report that CBD has a beneficial therapeutic action on established CIA.” Malfait AM et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9561-6.
    • 27. PARKINSON’S DISEASE Evidence suggests that cannabinoids may prove useful in Parkinson's disease by inhibiting the excitotoxic neurotransmitter glutamate and counteracting oxidative damage to dopaminergic neurons Croxford JL. Therapeutic potential of cannabinoids in CNS disease. CNS Drugs. 2003;17(3):179-202. It seems that cannabinoids could delay or even stop progressive degeneration of brain dopaminergic systems, a process for which there is presently no prevention. In combination with currently used drugs, cannabinoids might represent, qualitatively, a new approach to the treatment of PD, making it more effective. Sevcik J, Masek K Potential role of cannabinoids in Parkinson's disease DRUG AGING 16 (6): 391-395 JUN 2000
    • 28. ALZHEIMER’S DISEASE Memory loss, the first and primary symptom of Alzheimer’s disease, can be slowed down significantly in mice by cannabidiol. In a study at the Cajal Institute in Madrid, Spain, mice were injected with a molecule found in the brain of humans suffering from Alzheimer’s disease, and then treated for one week with cannabidiol. Those mice injected with cannabidiol successfully performed the task within 25-30 seconds, compared to control mice, who took almost double the amount of time, 45-50 seconds, to complete the task. See also: Iuvone T, Esposito G, Esposito R, et al. Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells J NEUROCHEM 89 (1): 134-141 APR 2004
    • 29. CANTERPENE AS AN ANTIAGING STRATEGY GOOD SCIENCE WITHOUT A METHOD TOGOOD SCIENCE WITHOUT A METHOD TO COMMERCIALIZE IT WILL NOT BENEFITCOMMERCIALIZE IT WILL NOT BENEFIT ANYONEANYONE
    • 30. Morris/Greg/Leah/Erin Rod Fisher Steve Burnside